# THE EFFECT OF NEBULIZED AZITHROMYCIN AS THERAPY FOR BRONCHOPULMONARY DYSPLASIA

> **NCT06584474** · PHASE4 · COMPLETED · sponsor: **Alexandria University** · enrollment: 100 (actual)

## Conditions studied

- Bronchopulmonary Dysplasia
- Premature
- Ventilation, Mechanical

## Interventions

- **DRUG:** Azithromycin neubilization
- **DEVICE:** Lung ultrasound

## Key facts

- **NCT ID:** NCT06584474
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-02
- **Primary completion:** 2025-06-02
- **Final completion:** 2025-07-02
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06584474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06584474, "THE EFFECT OF NEBULIZED AZITHROMYCIN AS THERAPY FOR BRONCHOPULMONARY DYSPLASIA". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06584474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*